---
title: "Novo Nordisk is embroiled in \"pay-for-delay\" agreement allegations regarding Victoza"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/273564504.md"
description: "Novo Nordisk has been accused of monopolizing the Victoza drug market in a U.S. federal court due to an illegal agreement with Teva Pharmaceutical Industries, delaying the launch of generic drugs until June 2024. J M Smith Company has filed a class action lawsuit, alleging that Novo Nordisk manipulated regulatory processes to prevent the FDA from approving competitors' generic drugs and seeking relief under the Sherman Act"
datetime: "2026-01-23T23:15:59.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/273564504.md)
  - [en](https://longbridge.com/en/news/273564504.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/273564504.md)
---

# Novo Nordisk is embroiled in "pay-for-delay" agreement allegations regarding Victoza

Novo Nordisk has been taken to court in a U.S. federal court, accused of monopolizing the Victoza drug market by entering into illegal agreements with Teva Pharmaceutical Industries Ltd. (an Israeli company) to delay the launch of generic drugs. J M Smith alleges that Novo Nordisk bribed Teva to postpone the launch of its Victoza generic drug until June 2024 and is seeking to initiate a class action lawsuit on behalf of direct purchasers. The lawsuit also claims that Novo Nordisk manipulated regulatory processes to prevent the U.S. Food and Drug Administration (FDA) from approving any potential competitors for Victoza and seeks relief under Section 2 of the Sherman Act

### Related Stocks

- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md)
- [VHT.US](https://longbridge.com/en/quote/VHT.US.md)
- [NVO.US](https://longbridge.com/en/quote/NVO.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [IHE.US](https://longbridge.com/en/quote/IHE.US.md)
- [XLV.US](https://longbridge.com/en/quote/XLV.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [TEVA.US](https://longbridge.com/en/quote/TEVA.US.md)
- [NVOX.US](https://longbridge.com/en/quote/NVOX.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)

## Related News & Research

- [Novo Nordisk identifies unauthorised data access from trials](https://longbridge.com/en/news/289576427.md)
- [Novo Nordisk to Seek China Approval for Wegovy Pill in Weeks or Months, CEO Says](https://longbridge.com/en/news/290053852.md)
- [Hacking group claims major hack of Novo Nordisk and attempted $25 million extortion](https://longbridge.com/en/news/289952343.md)
- [Novo Nordisk Expands 2026 Share Buyback, Holding 0.8% of Capital in Treasury Shares](https://longbridge.com/en/news/289779184.md)
- [The wrong prescription for drug affordability](https://longbridge.com/en/news/289929515.md)